"Bifidobacterium longum" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of Bifidobacterium that occurs in the human GASTROINTESTINAL TRACT and VAGINA. It inhibits the growth of pathogenic bacteria, may modulate the immune response, and is used as a PROBIOTIC.
| Descriptor ID |
D000069978
|
| MeSH Number(s) |
B03.510.024.100.500 B03.510.460.400.400.049.100.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bifidobacterium longum".
Below are MeSH descriptors whose meaning is more specific than "Bifidobacterium longum".
This graph shows the total number of publications written about "Bifidobacterium longum" by people in this website by year, and whether "Bifidobacterium longum" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 1 | 2 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Bifidobacterium longum" by people in Profiles.
-
Genome Features and In Vitro Activity against Influenza A and SARS-CoV-2 Viruses of Six Probiotic Strains. Biomed Res Int. 2021; 2021:6662027.
-
Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients with Lactose Intolerance and Persisting Functional Gastrointestinal Symptoms: A Randomised, Double-Blind, Cross-Over Study. Nutrients. 2019 Apr 19; 11(4).
-
A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation. Food Funct. 2019 Mar 20; 10(3):1595-1608.
-
Bifidobacterium longum and VSL#3® amelioration of TNBS-induced colitis associated with reduced HMGB1 and epithelial barrier impairment. Dev Comp Immunol. 2019 03; 92:77-86.
-
Targeting the gut microbiome to treat the osteoarthritis of obesity. JCI Insight. 2018 04 19; 3(8).
-
Inhibition effect of Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis and their related products on human colonic smooth muscle in vitro. PLoS One. 2017; 12(12):e0189257.
-
Effect of antibiotic, probiotic, and human rotavirus infection on colonisation dynamics of defined commensal microbiota in a gnotobiotic pig model. Benef Microbes. 2018 Jan 29; 9(1):71-86.